Eric C. Hsu

Insider Reports History

Entity
Individual
Location
C/O Inmed Pharmaceuticals Inc., Suite 310 815 Hastings Street, Vancouver, British Columbia, Canada
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric C. Hsu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
InMed Pharmaceuticals Inc. Sr. VP, Pre-Clinical Res/Dev Employee Stock Option (Right to Buy) 52.9K Dec 23, 2023 Direct
InMed Pharmaceuticals Inc. Sr. VP, Pre-Clinical Res/Dev Employee Stock Option (Expiration) 52K May 27, 2024 Direct
InMed Pharmaceuticals Inc. Sr. VP, Pre-Clinical Res/Dev Employee Stock Option (Right to Buy) 5.35K Dec 20, 2024 Direct

Insider Reports Filed by Eric C. Hsu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INM InMed Pharmaceuticals Inc. Dec 20, 2024 1 $0 4 Dec 23, 2024 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. May 27, 2024 1 $0 4 May 28, 2024 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. Mar 4, 2024 1 $0 4 Mar 5, 2024 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. Dec 23, 2023 1 $0 4 Dec 26, 2023 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. Aug 31, 2023 1 $0 4 Aug 31, 2023 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. May 16, 2023 1 $0 4 May 16, 2023 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. Mar 8, 2023 1 $0 4 Mar 9, 2023 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. Dec 16, 2022 1 $0 4 Dec 19, 2022 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. Nov 14, 2022 1 $0 4/A Nov 18, 2022 Sr. VP, Pre-Clinical Res/Dev
INM InMed Pharmaceuticals Inc. Oct 18, 2021 1 $0 4 Oct 19, 2021 Sr. VP, Pre-Clinical Res/Dev